Panel Discussion on: – Pharma Supply Chain – Finished Dosage Forms & Personalised Medicines
The following panel discussion takes into consideration the technological innovations and the key strategy developments of a few players involved in the Pharma Supply Chain. Companies have been invited to talk about the issues impacting the pharmaceutical development and manufacturing value chain.
TECHNOLOGICAL INNOVATIONS TO REACH HIGH VALUE PRODUCTS
This January – February issue, distributed at DCAT week ’20, is totally focused on the Pharma Supply Chain and deals as well with digitalisation, Pharma 4.0, biotechnologies and gene therapy. The following panel discussion takes into consideration the technological innovations and the key strategy developments of a few players involved in the chain.
From what we can learn from the inputs received, the main issues which are impacting the pharmaceutical development and manufacturing value chain are for sure quality, safety, sustainability, timeline and cost, drug shortages and regulatory compliance. Companies are facing these challenges by introducing technological innovations and key strategic developments, i.e. update of analytical and testing equipment, investments in new and high specialised technologies such as Flow Chemistry etc.
To complete this overview, we would like to propose again a Panel discussion on finished dosage forms and personalised medicines published in the September – October issue, 2019. This Panel considers the soli ...